
McKesson Corporation
MCKMcKesson Corporation (MCK) is a healthcare services and information technology company that distributes pharmaceuticals, medical supplies, and healthcare technology solutions. Founded in 1833, it has grown to become one of the largest healthcare distribution companies in North America, providing essential services to pharmacies, hospitals, and healthcare providers worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| July 1, 2026 | $0.82 | 2026-06-01 | 2026-06-01 |
| April 1, 2026 | $0.82 | 2026-03-02 | 2026-03-02 |
| January 2, 2026 | $0.82 | 2025-12-01 | 2025-12-01 |
| October 1, 2025 | $0.82 | 2025-09-02 | 2025-09-02 |
| July 1, 2025 | $0.71 | 2025-06-02 | 2025-06-02 |
Dividends Summary
- Consistent Payer: McKesson Corporation has rewarded shareholders with 90 dividend payments over the past 22 years.
- Total Returned Value: Investors who held MCK shares during this period received a total of $27.54 per share in dividend income.
- Latest Payout: The most recent dividend of $0.82/share was paid 17 days ago, on July 1, 2026.
- Yield & Schedule: MCK currently pays dividends quarterly with an annual yield of 0.39%.
- Dividend Growth: Since 2004, the dividend payout has grown by 1266.7%, from $0.06 to $0.82.
- Dividend Reliability: MCK has maintained or increased its dividend for 90 consecutive payments.
Company News
Eli Lilly and Teva Pharmaceutical represent two different pharmaceutical strategies: Eli Lilly dominates the high-growth GLP-1 market with blockbuster drugs like Mounjaro and Zepbound, posting 44% revenue growth and trading at a 33x forward P/E. Teva operates in generics and biosimilars with lower valuations (16.4x forward P/E) but faces declinin...
The global revenue cycle management (RCM) market is projected to grow at a CAGR of 11.51% from $200.1 billion in 2026 to $663.3 billion by 2035, driven by widespread EHR adoption, shift to value-based care models, and increasing use of AI and automation. North America holds the largest market share due to its complex healthcare system and advance...
The global healthcare analytics market is projected to grow from USD 56 billion in 2025 to USD 390 billion by 2034, with a CAGR of ~24%. Growth is driven by widespread EHR adoption, rising chronic disease prevalence, shift toward value-based care, AI/ML integration, and government digital health initiatives. North America leads with 44.36% market...
The global robotic pharmacy prescription market is experiencing significant growth, expanding from USD 214.16 million in 2025 to USD 237.65 million in 2026, with a projected CAGR of 9.18% through 2032, reaching USD 396.21 million. The market is driven by automation adoption for medication safety and efficiency, workforce transformation toward cli...
The biopharmaceutical third-party logistics market is expected to grow from $140.03 billion in 2025 to $384.23 billion by 2032, with a CAGR of 15.51%. Growth is driven by rising product complexity, regulatory scrutiny, cold chain integrity demands, and technological advancements in digital tracking and specialized handling for biologics and gene ...









